Quick Answer
REPLIGEN CORP reported Cash And Cash Equivalents At Carrying Value of $566.02 million for the year ending 2025.
- REPLIGEN CORP showed a decrease of -25.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from REPLIGEN CORP's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2010 to 2025), REPLIGEN CORP's Cash And Cash Equivalents At Carrying Value has grown by 4,418.8%.
- Historical annual values: Fiscal year 2025: $566.02 million | Fiscal year 2024: $757.36 million | Fiscal year 2023: $751.32 million | Fiscal year 2022: $523.46 million | Fiscal year 2021: $603.81 million | Fiscal year 2020: $717.29 million | Fiscal year 2019: $528.39 million | Fiscal year 2018: $193.82 million | Fiscal year 2017: $173.76 million | Fiscal year 2016: $122.23 million | Fiscal year 2015: $54.09 million | Fiscal year 2014: $35.36 million | Fiscal year 2013: $39.83 million | Fiscal year 2012: $29.21 million | Fiscal year 2011: $11.17 million | Fiscal year 2011: $14.20 million | Fiscal year 2010: $9.79 million | Fiscal year 2010: $12.53 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: